5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102

5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC

5/20/2025ArkBio Announces Positive Phase II Results of AK3280

5/20/2025SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration

5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial

5/20/2025WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal

5/20/2025JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...

5/20/2025Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...

5/20/2025Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...

5/20/2025Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio

5/16/2025WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...

5/16/2025Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery

5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...

5/16/2025US Push to Decouple from China May Spike Drug Costs, Experts Warn

5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...

5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease

5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...

5/16/2025CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...

5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...

5/16/2025ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...

5/15/2025Hengrui Aims to Raise $1.27B in Hong Kong IPO

5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...

5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...

5/14/2025Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...

Page:1/49 Total number of articles:1467: [First][<<] [1] [2] [3] [4] [5] [>>] [End]